Clinical Trial Update: Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the minimal effective analgesic concentration (MEAC 90) of ropivacaine for interscalene block in postoperative pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Snippet

Sponsor: Healthpoint Hospital | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN